Adenovirus infections in immunocompetent and immunocompromised patients
T Lion - Clinical microbiology reviews, 2014 - Am Soc Microbiol
Human adenoviruses (HAdVs) are an important cause of infections in both
immunocompetent and immunocompromised individuals, and they continue to provide …
immunocompetent and immunocompromised individuals, and they continue to provide …
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
Despite extensive global efforts in the fight against killer infectious diseases, they still cause
one in four deaths worldwide and are important causes of long-term functional disability …
one in four deaths worldwide and are important causes of long-term functional disability …
[HTML][HTML] Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
S Prockop, E Doubrovina, S Suser… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Adoptive transfer of donor-derived EBV-specific cytotoxic T-lymphocytes
(EBV-CTLs) can eradicate EBV-associated lymphomas (EBV-PTLD) after transplantation of …
(EBV-CTLs) can eradicate EBV-associated lymphomas (EBV-PTLD) after transplantation of …
[HTML][HTML] Strategies of adoptive T-cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
T Kaeuferle, R Krauss, F Blaeschke, S Willier… - Journal of hematology & …, 2019 - Springer
Background Allogeneic hematopoietic stem cell transplantation (HSCT) can expose patients
to a transient but marked immunosuppression, during which viral infections are an important …
to a transient but marked immunosuppression, during which viral infections are an important …
T cells for viral infections after allogeneic hematopoietic stem cell transplant
CM Bollard, HE Heslop - Blood, The Journal of the American …, 2016 - ashpublications.org
Despite recent advances in the field of allogeneic hematopoietic stem cell transplantation
(HSCT), viral infections are still a major complication during the period of immune …
(HSCT), viral infections are still a major complication during the period of immune …
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
M Neuenhahn, J Albrecht, M Odendahl, F Schlott… - Leukemia, 2017 - nature.com
Cytomegalovirus (CMV) infection is a common, potentially life-threatening complication
following allogeneic hematopoietic stem cell transplantation (allo-HSCT). We assessed …
following allogeneic hematopoietic stem cell transplantation (allo-HSCT). We assessed …
Virus-specific T-cell banks for'off the shelf'adoptive therapy of refractory infections
Adoptive immunotherapy with transplant donor-derived virus-specific T cells has emerged
as a potentially curative approach for the treatment of drug-refractory EBV+ lymphomas as …
as a potentially curative approach for the treatment of drug-refractory EBV+ lymphomas as …
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
B Withers, E Blyth, LE Clancy, A Yong… - Blood …, 2017 - ashpublications.org
Donor-derived adoptive T-cell therapy is a safe and effective treatment of viral infection
posttransplant, but it is limited by donor serostatus and availability and by its personalized …
posttransplant, but it is limited by donor serostatus and availability and by its personalized …
[HTML][HTML] Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
M Uhlin, H Wikell, M Sundin, O Blennow… - …, 2014 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation is a successful treatment for hematologic
malignancies and a variety of genetic and metabolic disorders. In the period following stem …
malignancies and a variety of genetic and metabolic disorders. In the period following stem …
[HTML][HTML] American Society for Transplantation and Cellular Therapy Series:# 4-Cytomegalovirus treatment and management of resistant or refractory infections after …
MK Yong, TL Shigle, YJ Kim, PA Carpenter… - … and Cellular Therapy, 2021 - Elsevier
Abstract The Practice Guidelines Committee of the American Society of Transplantation and
Cellular Therapy (ASTCT) partnered with its Transpl. Infect. Dis. Special Interest Group (TID …
Cellular Therapy (ASTCT) partnered with its Transpl. Infect. Dis. Special Interest Group (TID …